Advertisement

Topics

Merus, Ono Pharma Enter New Agreement

04:51 EDT 14 Mar 2018 | Contract Pharma

For Merus’ Biclonics® technology platform to generate a bispecific antibody that treats autoimmune diseases

Original Article: Merus, Ono Pharma Enter New Agreement

NEXT ARTICLE

More From BioPortfolio on "Merus, Ono Pharma Enter New Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...